Kilitch Drugs Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA813
EBIT611
Earning Per Share24
Expenses63104
Net Profit46
Net Profit Margin55
Operating Profit Margin1112
Profit Before Tax510
Dividends Per Share00
Operation Revenue71117

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
2023008,560.84NA9,408.43
2023002,835.49NA4,038.35
202300372.90NA385.50
202300103.87NA140.39
20221,257.602,182.90978.507,628.101,190
The EBITDA of Kilitch Drugs is 13 as of 11/30/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities104463
Investing Activities-4-14-10-388
Financing Activities61712-1
Others00000
Net Cash Flow23-51010

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
20234,959.33-7,943.682,376.07-608.28
20223,325.90-1,871.88-1,599.79-145.77
2023723.95-447.59-261.9614.40
2020140.90-44.50-38.5557.85
2017640-498.50-177.50-36
The cash flow from Operating Activities of Kilitch Drugs is 3 as of 11/30/2023